Repligen
RGEN
#2527
Rank
NZ$12.15 B
Marketcap
NZ$215.88
Share price
-3.68%
Change (1 day)
-22.12%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$4.90 Billion

According to Repligen 's latest financial reports the company's total assets are NZ$4.90 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$5.01 B12.07%
2023-12-31NZ$4.47 B12.28%
2022-12-31NZ$3.98 B15.49%
2021-12-31NZ$3.45 B30.92%
2020-12-31NZ$2.63 B26.86%
2019-12-31NZ$2.07 B80.02%
2018-12-31NZ$1.15 B10.31%
2017-12-31NZ$1.04 B151%
2016-12-31NZ$0.41 B95.21%
2015-12-31NZ$0.21 B30.49%
2014-12-31NZ$0.16 B13.41%
2013-12-31NZ$0.14 B22.43%
2012-12-31NZ$0.11 B
2011-03-31NZ$95.03 M-5.82%
2010-03-31NZ$0.10 B-22.43%
2009-03-31NZ$0.13 B51.92%
2008-03-31NZ$85.62 M110.73%
2007-03-31NZ$40.63 M-14.01%
2006-03-31NZ$47.25 M21.76%
2005-03-31NZ$38.8 M-12.53%
2004-03-31NZ$44.36 M-8.31%
2003-03-31NZ$48.38 M-26.75%
2002-03-31NZ$66.05 M-18.4%
2001-03-31NZ$80.95 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
NZ$350.04 B 7,039.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$172.76 B 3,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$218.29 B 4,352.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$150.99 B 2,979.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.14 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$1.97 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.76 B 58.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$4.23 B-13.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$12.77 B 160.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$12.60 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA